Hawaii Legislature Considers Protecting Employees Who Use Medical Cannabis

Hawaii Legislature Considers Protecting Employees Who Use Medical Cannabis

This past January, Hawaii Senators Rosalyn Baker (D) and Brian Taniguchi (D) introduced Senate Bill 2543, a bill that would grant employment protection to employees who use cannabis. Although the bill was introduced months ago, it is still making its way through the legislature. 

According to the wording of the bill, employers in Hawaii could lose monetary or licensing benefits if they fail to protect employees who use medical cannabis. Discrimination against patients when hiring, firing, or making any changes to employment would be prohibited. Discrimination will not be allowed against medical cannabis card holders or those who test positive for medical cannabis and are legally allowed to take it. The one exception will be for “potentially dangerous occupations,” which at this time are not clearly defined in the bill. 

However, it does list certain professions that will be exempt from this, sticking with a no-cannabis policy. That includes law enforcement officers, firefighters, water safety officers, those who have to carry firearms for work, emergency personnel, anyone who works with controlled substances in the healthcare field, anyone who works with vulnerable populations such as children and the elderly, civil defense personnel, and those with certain types of vehicle licenses. Additionally, those who work with public power grids and public utilities will not be able to use medical cannabis. 

“Medical cannabis patients face significant stigma due to longstanding misperceptions regarding cannabis and its uses, fueled by a longstanding, costly ‘war on drugs’ that is disproportionately waged against those impacted by social determinants of health,” officials with the Drug Policy Forum of Hawaii said in a written testimony released when the bill was first introduced. 

Read More

Published at Thu, 04 Jun 2020 15:08:41 +0000

2 Marijuana Stocks That Want To Change The Cannabis Industry

2 Marijuana Stocks That Want To Change The Cannabis Industry




2 Marijuana Stocks That Want To Change The Cannabis Industry | Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™























Published at Thu, 04 Jun 2020 15:41:57 +0000

2 Marijuana Stocks That Want To Change The Cannabis Industry

2 Marijuana Stocks That Want To Change The Cannabis Industry




2 Marijuana Stocks That Want To Change The Cannabis Industry | Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™























Published at Thu, 04 Jun 2020 15:41:57 +0000

Choom Announces Strategic Acquisition of Phivida Accelerating Digital Strategy and Strengthens its Balance Sheet

Choom Announces Strategic Acquisition of Phivida Accelerating Digital Strategy and Strengthens its Balance Sheet

Vancouver, British Columbia, June 03, 2020 (GLOBE NEWSWIRE) —
 

  • Transaction strengthens Choom’s leadership position in Canadian cannabis retail
  • Choom poised for accelerated growth with omni-channel retail growth strategy
  • Strategically timed to benefit from the continued Ontario retail rollout
  • Compelling value-creation opportunity with defensible store portfolio in flagship locations
  • Enhanced capital markets presence and balance sheet strength to fuel growth in 2020 and beyond
  • Combines the strength of Choom and Phivida’s executive teams, national relationships and strategic shareholders with capabilities across retail, branding and digital analytics

Choom Holdings Inc. (“Choom”) (CSE: CHOO; OTCQB: CHOOF) and Phivida Holdings Inc. (“Phivida”) (CSE: VIDA) are pleased to announce that they have entered into a definitive arrangement agreement dated June 2, 2020  (the “Arrangement Agreement”) pursuant to which Choom will acquire all of the issued and outstanding common shares of Phivida (the “Phivida Shares”) in exchange for common shares of Choom (the “Choom Shares”) in an arm’s length all-share transaction valued at approximately $7.3 million (the “Transaction”).

Under the terms of the Arrangement Agreement, Phivida shareholders will receive 0.72566 of a Choom Share in exchange for each Phivida Share held (the “Exchange Ratio”) based on $0.082 per Phivida Share, representing a 10% premium to the 20-day volume weighted average price of the Phivida Shares ending June 2, 2020, and based on a 20-day volume weighted average price of the Choom Shares for the same period, being $0.113 per Choom Share. Based on the closing price of the Phivida Shares on June 2, 2020, the Transaction results in an implied premium of approximately 20% per Phivida Share.

Upon completion of the Transaction, existing Choom and Phivida shareholders will hold approximately 78% and 22% of the pro forma company, respectively, on a fully diluted basis.

“The acquisition of Phivida will further Choom’s ability to deliver on our business plans and accelerate our growth initiatives, enabling our omni-channel strategy through enhanced digital capabilities, and an expanded brick-and-mortar presence across Canada,” said Corey Gillon, CEO of Choom. “The timing is ideal as we prepare to expand our retail footprint in Ontario, Canada’s largest market for cannabis sales, later this year, with several flagship locations already secured.”

David Moon CEO of Phivida, added: “Following an extensive evaluation of the Canadian cannabis market, we’re thrilled to partner with Choom and continue to execute on our digital growth strategy which will be complimentary to Choom’s brick and mortar retail store growth. By leveraging consumer data collected through our online websites and working with the Choom team to enhance in store analytics, we are well positioned to optimize our business for continued success.”

Strategic Rationale
The Transaction is expected to enhance Choom’s strategy in becoming one of the dominant national retail players in the Canadian cannabis retail sector. More specifically, the Transaction is expected to:

Enhance Choom’s Leadership Position in Cannabis Retail: Leveraging Choom’s current brick and mortar retail presence with Phivida’s digital assets and branded product expertise, the combined company will benefit from a vertically integrated strategy focused on cannabis retail and consumer experiences.
Accelerate National Store-Roll out Program: Upon completion of the Transaction, Choom will leverage Phivida’s current assets, to accelerate the build-out of additional stores in Ontario and British Colombia. The combined company will further benefit from its deep relationships with prominent landlords to support future store growth at marquee locations.
Strengthen Choom’s Digital Strategy & Analytics: Choom will leverage Phivida’s digital assets and capabilities to enhance growth and consumer experiences in its retail stores by utilizing Phivida’s strong e‑commerce solutions and content-rich marketing platforms.
Enhance Scale and Access to Capital: The combined company will benefit from enhanced capital markets presence and a broader shareholder group with strengthened access to growth capital.
Bolster Management Team with Added Capabilities and Broader Stakeholders: The combined company will have blue-chip retail and branded product capabilities, digital and online expertise, countrywide geographical representation, and an aligned entrepreneurial spirit committed to creating one of the dominant national cannabis retailers in Canada.

Transaction Summary
The Transaction will be effected by way of a court-approved plan of arrangement completed under the Business Corporations Act (British Columbia) and will require approval by at least 66 2/3% of the votes cast by the shareholders of Phivida at a special meeting of Phivida shareholders. In addition to shareholder approval, the Transaction is subject to applicable regulatory, court and stock exchange approvals and certain other closing conditions customary in transactions of this nature.

The Arrangement Agreement has been unanimously approved by the boards of directors of Choom and Phivida, and the Phivida board has recommended that Phivida shareholders vote in favour of the Transaction.  A management information circular will be mailed to Phivida shareholders in connection with a meeting of Phivida shareholders to consider and approve the Transaction. The board of directors of Phivida has obtained a fairness opinion from Haywood Securities Inc. that, as of the date of the opinion, and subject to the assumptions, limitations, and qualifications on which such opinion is based, the consideration to be received by Phivida’s shareholders pursuant to the Arrangement Agreement is fair, from a financial point of view, to the Phivida shareholders.

Directors and officers of Phivida as well as certain Phivida shareholders holding, in aggregate, approximately 31% of the issued and outstanding common shares of Phivida, have entered into support and voting agreements pursuant to which they have agreed to vote their Phivida Shares in favour of the Transaction.

The Arrangement Agreement includes customary provisions including reciprocal non-solicitation provisions, subject to the right of each of Choom and Phivida to accept a superior proposal in certain circumstances, with both Choom and Phivida having a seven business day right to match any such superior proposal for the other party. The Arrangement Agreement also provides for reciprocal termination fees of $500,000 if the Transaction is terminated in certain specified circumstances, as well as a reciprocal payment of a $250,000 expense reimbursement fee if the Transaction is terminated in certain other specified circumstances.

Upon completion of the Transaction, Choom’s board of directors will be reconstituted to comprise three directors nominated by Choom and one director nominated by Phivida. A fifth director, mutually agreed upon by Phivida and Choom, will subsequently be added to the board.

None of the securities to be issued pursuant to the Arrangement Agreement have been or will be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”), or any state securities laws, and any securities issued in the Arrangement are anticipated to be issued in reliance upon the exemption from such registration requirements provided by Section 3(a)(10) of the U.S. Securities Act and applicable exemptions under state securities laws. This news release does not constitute an offer to sell or the solicitation of an offer to buy any securities.

Advisors and Counsel
BDO Transaction Advisory Services Inc. is acting as the exclusive financial advisor to Choom. Pushor Mitchell LLP is acting as legal counsel to Choom.

Hillcrest Merchant Partners Inc. is acting as the exclusive financial advisor to Phivida. Phivida received an independent fairness opinion from Haywood Securities Inc. Gowling WLG (Canada) LLP is acting as legal counsel to Phivida.

About Choom

Choom is a fast-expanding retail cannabis company who has established one of the largest store networks in Canada. The Choom brand is inspired by Hawaii’s “Choom Gang” – a group of buddies in Honolulu during the 1970’s who loved to smoke weed – or as the locals called it, “Choom”. Evoking the spirit of the original Choom Gang, our brand caters to the Canadian market with the ethos of ‘cultivating good times’. Choom is focused on delivering an elevated customer experience through our curated retail environments, offering a diversity of brands for Canadians across a national retail network. For more information, visit www.choom.ca.

About Phivida

Phivida Holdings Inc. is a CBD-centric holding group with assets in technology, publishing and consumer-packaged goods (CPG). Headquartered in Vancouver BC, with operations in San Diego, Toronto and Belgrade, Phivida produces a line of CBD-infused foods and beverages (OKI), and CBD topicals and supplements (VIDA+), in addition to managing and operating two CBD-related, online retail marketplaces under the brand names Bloomgroove and Wikala. Greencamp is Phivida’s online publication and knowledge center on CBD sector news. For more information, visit www.phivida.com.

Cautionary Note Regarding Forward-Looking Information

This news release contains “forward-looking information” within the meaning of applicable Canadian securities legislation. Often, but not always, forward-looking information can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking statements or information involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Choom, Phivida or their respective subsidiaries to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information contained in this news release. Statements containing forward-looking information include, but are not limited to, statements relating to our expectations with respect to: the timing and outcome of the Transaction; the anticipated benefits of the Transaction to the parties and their respective securityholders; and the impact of the Transaction on the parties’ respective businesses on a combined basis, and the anticipated growth of the combined company and how the Transaction are expected to enhance the parties’ respective future business plans.

In respect of the forward-looking information in this news release concerning the anticipated benefits and completion of the Transaction and the anticipated timing for completion of the Transaction, Choom and Phivida have provided such statements and information in reliance on certain assumptions that they believe are reasonable at this time, including assumptions as to the time required to prepare and mail security holder meeting materials; the ability of the parties to receive, in a timely manner and on satisfactory terms, the necessary regulatory, court and shareholder approvals; the ability of the parties to satisfy, in a timely manner, the other conditions to the closing of the Transaction; other expectations and assumptions concerning the Transaction. Although Choom and Phivida believe that the assumptions and factors used in preparing the forward-looking information or forward-looking statements in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all.

Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information, including; risks that the Arrangement will not close as anticipated or at all, risks that required shareholder, regulatory or other approvals will not be obtained or may be materially delayed, risks that the synergies expected as a result of the Transaction will not be realized as anticipated or at all, integration risks following completion of the Transaction, risks associated with general economic conditions, including adverse conditions resulting from the ongoing COVID-19 pandemic and the resulting government policies restricting mobility, assembly or contact with actual and potential customers and suppliers; future legislative and regulatory developments; inability to access sufficient capital on favourable terms or at all, and such other risks identified in Choom’s and Phivida’s most recent management’s discussions and analysis filed with Canadian securities regulators and which are available on Choom’s and Phivida’s respective issuer profile on SEDAR at www.sedar.com. Readers are cautioned that the foregoing list of factors is not exhaustive.

The forward-looking statements included in this news release are made as of the date of this news release and Choom and Phivida do not undertake an obligation to publicly update such forward-looking information or forward-looking information to reflect new information, subsequent events or otherwise unless required by applicable securities laws. There can be no assurance that the Transaction will occur, or that it will occur on the terms and conditions contemplated in this news release. The Transaction could be modified, restructured or terminated. Actual results could differ materially from those currently anticipated due to a number of factors and risks. Completion of the Transaction is subject to a number of conditions, including but not limited to the approval of the Canadian Securities Exchange and the approval of shareholders of Phivida. The Transaction cannot close until the required shareholder, court and regulatory approval is obtained.

There can be no assurance that the Transaction will be completed as proposed or at all. Investors are cautioned that, except as disclosed in the management information circular to be prepared in connection with a meeting of Phivida shareholders to consider the Transaction, any information released or received with respect to the Transaction may not be accurate or complete and should not be relied upon. The Canadian Securities Exchange has in no way passed upon the merits of the Transaction, and has neither approved nor disapproved the contents of this news release.

Contacts: Choom – Corey Gillon, CEO, Telephone: 1 (604) 683-2509, Email investors@choom.ca. Phivida – David Moon, Interim CEO, Telephone: 1 (844) 744-6646 x2, Email IR@Phivida.com.
 

Read More

Published at Wed, 03 Jun 2020 20:16:51 +0000

Delta 9 Cannabis Inc. Purchases Two Stores In Alberta

Delta 9 Cannabis Inc. Purchases Two Stores In Alberta

WINNIPEG, Manitoba, June 1, 2020 (GLOBE NEWSWIRE) – PRESS RELEASE – Delta 9 Cannabis Inc. closed a deal on May 29 to purchase two cannabis retail locations in Alberta, Canada. Delta 9 is a vertically integrated cannabis company based in Winnipeg, Manitoba, and the stores, located in Calgary, Alberta, and Grande Prairie, Alberta, were acquired from Modern Leaf Group Inc. The purchase had been agreed upon Nov. 21, 2019. The purchase was made through Delta 9 Cannabis Store Inc. a wholly owned Delta 9 subsidiary.

“We are pleased to have finalized our transaction with Modern Leaf and look forward to the first Delta 9 Cannabis Stores opening their doors in the province of Alberta in short order,” said John Arbuthnot, CEO of Delta 9.

Delta 9 Cannabis Store Inc. purchased the stores for $1.3 million subject to customary adjustments. $1,000,000 of the purchase price was satisfied through the issuance of 1,250,000 common shares in the capital stock of the Delta 9.

Upon the closing of the transaction, Delta 9 and Modern Leaf entered into additional agreements granting a right of first refusal by Modern Leaf in favor of Delta 9 pertaining to the purchase of a retail cannabis store located in Olds, Alberta, and the granting of certain restrictive covenants by Modern Leaf in favor of Delta 9.

Published at Wed, 03 Jun 2020 18:45:00 +0000

Cannabis Conference Launches Video Access to 2019 Educational Sessions

Cannabis Conference Launches Video Access to 2019 Educational Sessions

AWH, a multistate, vertically integrated cannabis operator, announced June 1 the opening of two Michigan Supply & Provisions (MS&P) retail locations in Detroit and Battle Creek, Mich.

The two new dispensaries are the latest locations MS&P will open in 2020 across Michigan. MS&P will launch its new medical-only, flagship dispensary in Detroit June 4 following the opening of its new adult-use store in Battle Creek June 2 . The two new locations are the second and third for MS&P in the state, after the company opened one of Michigan’s first adult-use dispensaries in Morenci in December  2019.

RELATED: Michigan Launches Adult-Use Sales With Soft Open

Both locations will include online pre-ordering and appointment pick up options, which will significantly reduce wait times while keeping patients, customers and employees safe as the industry continues to navigate the novel coronavirus pandemic

The Detroit location will include a staff of 15 full-time employees in the 2,500-square-foot store, and its products will include flower, vapes, concentrates, edibles and topicals. The adult-use Battle Creek dispensary is 1,600 square feet and will include a team of 25 full-time employees.

AWH, which also operates cannabis companies in Illinois, Massachusetts, Ohio and New Jersey, plans to launch a new 144,000 square foot cultivation and processing facility in Lansing, in addition to three more dispensaries in 2020.

Published at Tue, 02 Jun 2020 19:16:00 +0000

California’s Cannabis Excise Tax Generated $68.3M For Q1 2020

California’s Cannabis Excise Tax Generated $68.3M For Q1 2020

The California Department of Tax and Fee Administration (CDTFA) reported revenue numbers [yesterday] for cannabis sales for the 1st Quarter of 2020. As of May 15, 2020, California’s cannabis excise tax generated $68.3 million in revenue reported on the 1st Quarter 2020 returns due by April 30, 2020, and the cultivation tax generated $16.4 million.

Due to the COVID-19 pandemic, 1st Quarter 2020 is a unique reporting period since approximately half of the taxpayers normally reporting have yet to file a return with the CDTFA. Revisions to 1st Quarter 2020 data are expected in mid-August after the 2nd Quarter return filing due date of July 31. Additional information on the relief offered due to the COVID-19 pandemic can be found at COVID-19 State of Emergency.

Sales tax from cannabis businesses totaled $50.2 million in revenue for the same period. Sales tax applies to sales of cannabis, cannabis products, and other tangible personal property. Certain retail sales of medicinal cannabis are exempt from sales and use taxes when the purchaser provides at the time of purchase a valid Medical Marijuana Identification Card issued by the California Department of Public Health and a valid government-issued identification card.

Total tax revenue reported by the cannabis industry is $134.9 million for 1st Quarter returns due by April 30, 2020. This does not include tax revenue collected by each jurisdiction. Previously reported revenue for 4th Quarter 2019 returns was revised to $177.3 million, which included $85.9 million in cannabis excise tax, $24.1 million in cultivation tax, and $67.3 million in sales tax. Revisions to quarterly data are the result of amended and late returns, and other tax return adjustments.

Read More

Published at Tue, 02 Jun 2020 15:42:47 +0000

Red Lake Nation In Minnesota Approves Medical Cannabis Reforms

Red Lake Nation In Minnesota Approves Medical Cannabis Reforms

Minnesota’s Red Lake Nation on Wednesday overwhelmingly approved a medical cannabis program that goes beyond the state’s program parameters and allowing flower, Red Lake Nation Newsreports. The measure passed 1,765 to 425, or 80 percent approval.

Cannabis advocate Kevin Jones, who also organized the Chippewa Cannabis Party, said the tribe would also have about 20 more qualifying conditions than the state program and that the tribal program will allow program access for opioid addiction.

“I hope it helps the opioid crisis, we got hit hard with that. I hope that changes a lot of it and helps families bring parents, aunties and uncles back to where they were before. It won’t bring the ones we lost back but will make a new path for the ones on that journey today.” – Jones to the Red Lake Nation News

Jones noted in an interview with the Duluth Reader that when Minnesota launched its medical cannabis program, they didn’t include tribes in the reforms. Jones said the vote sets the stage for the tribe to go “full recreational” despite Minnesota laws and that the tribe would exercise its sovereignty on the issue.

Read More

Published at Mon, 01 Jun 2020 13:55:31 +0000

Nextleaf Solutions Receives Patents for Cannabis Oil Extraction in North America, Europe, and Asia

Nextleaf Solutions Receives Patents for Cannabis Oil Extraction in North America, Europe, and Asia

Nextleaf Solutions Ltd. (“Nextleaf“, “OILS“, or the “Company“) (CSE: OILS) (OTCQB: OILFF), Canada’s most innovative cannabis extractor, announced today that it has been issued more patents in North America, Asia, and Europe. These additional patents were awarded in jurisdictions including, but not limited to: the United States; Spain; Portugal; Poland; Malta; Ireland; Denmark; and, Cambodia. These latest issued patents pertain to the Company’s unique method of extracting and separating cannabinoids and terpenes.

Nextleaf Solutions Ltd. (CNW Group/Nextleaf Solutions Ltd.)

These patents extend the Company’s existing patent portfolio to protect methodologies relating to the removal of fats and waxes during the extraction and purification process, achieving more efficient throughput rates and a higher quality distillate. Less refined cannabis extracts contain chlorophyll, fats, and other impurities that result in undesirable flavours and aromas.

With the latest patent issuances, OILS has advanced its intellectual property (“IP“) stack to over 35 issued patents, and 65 pending patents, for the industrial-scale extraction, and distillation of cannabinoids. With a 100% pending application to issued patent success rate, the Company has developed defendable IP around the most efficient methods for producing distilled THC and CBD at scale within a regulated environment.

OILS considers European IP protection to be particularly important due to the increasing demand for medical cannabis and CBD products in these rapidly legalizing markets. Prohibition Partners projects the legal European cannabinoid market will be worth more than US$39 billion by 2024, compared to US$37 billion for the more mature North American market by the same time.

The Company’s patent portfolio includes protection around the methodologies and technology necessary to efficiently process dried cannabis and hemp biomass into high-purity THC and CBD oils that are used in the manufacturing of cannabinoid formulations and products.

“We expect these patents will have a major impact on the production and sale of standardized cannabinoid-based products in Europe over the twenty year life of the patents,” said Paul Pedersen, CEO. “These are jurisdictions that collectively manufacture and export over 70% of all drugs and medicines consumed globally, making European IP protection very important to our long-term global strategy”, continued Pedersen.

Employee Equity Participation Plan

The Company announced today that it has issued shares under its Employee Equity Participation Plan (the “Plan“) implemented on April 1st in response to the COVID-19 pandemic to align the efforts and compensation of non-executive employees with the Company’s long-term business strategy.

The Plan is fully voluntary and permits non-executive employees to receive common shares in the capital of the Company in lieu of a portion of an employee’s cash compensation. The Plan allows the Company to reduce the cash component of employee compensation and further align incentives across the team.

Under the Plan for the month of May, Nextleaf has issued an aggregate of 88,701 common shares at a price of $0.315 per share.

Timing of Q2 2020 Financial Results

Due to logistical issues and delays caused by the COVID-19 virus, the Company is relying on the exemption provided in BC Instrument 51-517 Temporary Exemption from Certain Corporate Finance Requirements with Deadlines during the Period from June 2 to August 31, 2020 (and similar exemptions provided by other Canadian securities regulators) (the “BC Instrument“) to postpone the filing of the following continuous disclosure documents (collectively, the “Documents“):

  • the Company’s interim financial statements for the three and six month periods ended March 31, 2020 and related certifications; and
  • the Company’s management discussion and analysis for the three and six month periods ended March 31, 2020.

The BC Instrument provides the Company with an additional 45 days from the deadline otherwise applicable under British Columbia securities laws to make the filing. Until the Company has filed the Documents, members of the Company’s management and other insiders are subject to a trading blackout reflecting the principles contained in section 9 of National Policy 11-207 Failure to File Cease Trade Orders and Revocations in Multiple Jurisdictions such that they are in a blackout  period until the end of the second trading day after the Documents have been disclosed by way of a news release.

At this time, the Company expects to file the Documents by July 16, 2020. There have been no material business developments since the filing of the Company’s audited annual financial statements and associated management’s discussion and analysis for the three months ended December 31, 2019 that have not been otherwise disclosed by the Company by way of news release.

About Nextleaf®

OILS is Canada’s most innovative cannabis extractor, developing technology for extracting and distilling THC and CBD oils. Nextleaf’s industrial-scale extraction plant in Metro Vancouver has a design capacity to process 600 kg per day of dried cannabis biomass into distilled oils. The Company owns a portfolio of over 35 issued patents and 65 pending patents for the extraction and distillation of cannabinoids. Nextleaf Solutions commercializes its patent portfolio through IP licensing, and supplying THC and CBD oils through Nextleaf Labs, a Health Canada licensed standard processor.

Nextleaf Solutions trades as OILS on the Canadian Securities Exchange, OILFF on the OTCQB Market in the United States, and L0MA on the Frankfurt Stock Exchange.

Follow OILS across social media platforms: TwitterLinkedInFacebook, and Instagram.
www.nextleafsolutions.com

For further information, please contact:
604-283-2301 (ext. 219)
investors@nextleafsolutions.com

On behalf of the Board of Directors of the Company,
Paul Pedersen, CEO

Certain statements contained in this press release constitute “forward-looking statements”. All statements other than statements of historical fact contained in this press release, including, without limitation, those regarding the Company’s ability to capitalize on its IP portfolio, expectations regarding lower costs resulting from utilization of the Company’s technology, changes in the global market for cannabinoid-based products, the potential for shareholder value creation through the formalization and protection of IP, expected IP licensing revenues, the Company’s  strategy, plans, objectives, goals and targets, and any statements preceded by, followed by or that include the words “believe”, “expect”, “aim”, “intend”, “plan”, “continue”, “will”, “may”, “would”, “anticipate”, “estimate”, “forecast”, “predict”, “project”, “seek”, “should” or similar expressions or the negative thereof, are forward-looking statements. These statements are not historical facts but instead represent only the Company’s expectations, estimates and projections regarding future events. These statements are not guarantees of future performance and involve assumptions, risks and uncertainties that are difficult to predict. Therefore, actual results may differ materially from what is expressed, implied or forecasted in such forward-looking statements. Additional factors that could cause actual results, performance or achievements to differ materially include, but are not limited to the risk factors discussed in the Company’s MD&A for the most recent fiscal period. Management provides forward-looking statements because it believes they provide useful information to investors when considering their investment objectives and cautions investors not to place undue reliance on forward-looking information. Consequently, all of the forward-looking statements made in this press release are qualified by these cautionary statements and other cautionary statements or factors contained herein, and there can be no assurance that the actual results or developments will be realized or, even if substantially realized, that they will have the expected consequences to, or effects on, the Company. These forward-looking statements are made as of the date of this press release and the Company assumes no obligation to update or revise them to reflect subsequent information, events or circumstances or otherwise, except as required by law. The CSE has not reviewed, approved or disapproved the contents of this press release.

Cision

View original content to download multimedia:http://www.prnewswire.com/news-releases/nextleaf-solutions-receives-patents-for-cannabis-oil-extraction-in-north-america-europe-and-asia-301068340.html

SOURCE Nextleaf Solutions Ltd.

Cision View original content to download multimedia: http://www.newswire.ca/en/releases/archive/June2020/01/c8972.html

Published at Mon, 01 Jun 2020 13:28:31 +0000